Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the life sciences, biotechnology, and pharmaceutical industries. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of organizations, collaborators, and partners around the world, from academic teams and venture-backed biotechnology companies to large pharmaceutical companies. As an AAALAC accredited, GLP compliant CRO, we leverage our unique portfolio of clinically relevant models, extensive nonhuman primate research resources and capabilities, and focused therapeutic domain expertise results in program engagements that generate high value, clinically relevant data that yields definitive, actionable study outcomes.
Visit us at www.virscio.com to learn more.